Investor Alert

Edwards Lifesciences Corp.



After Hours

 --Quotes are delayed by 20 min

May 14, 2021, 7:37 p.m.





-0.17 -0.19%


Volume 48,308

Quotes are delayed by 20 min


Previous close

$ 87.94

$ 89.49


+1.55 +1.76%

Day low

Day high




52 week low

52 week high




Annual Financials for Edwards Lifesciences Corp.

Operating Activities

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Net Income before Extraordinaries 569.5M583.6M722.2M1.05B823.4M
Depreciation, Depletion & Amortization 71.2M81.9M77.4M114.6M135.4M
Depreciation and Depletion 63.6M74.1M74.9M110M130M
Amortization of Intangible Assets 7.6M7.8M2.5M4.6M5.4M
Deferred Taxes & Investment Tax Credit (37.4M)17.8M(27.3M)12.1M(49.4M)
Deferred Taxes (37.4M)17.8M(27.3M)12.1M(49.4M)
Investment Tax Credit -----
Other Funds 35M83.2M197.1M210.1M102.7M
Funds from Operations 638.3M766.5M969.4M1.38B1.01B
Extraordinaries -----
Changes in Working Capital 66.1M234.2M(42.6M)(204.3M)42.2M
Receivables (56.7M)(3.9M)(28.7M)(88M)41.9M
Accounts Payable 74M85.2M192.5M(63.5M)(84.5M)
Other Assets/Liabilities 9.3M(1.5M)17.1M9.4M258.3M
Net Operating Cash Flow 704.4M1B926.8M1.18B1.05B

Investing Activities

20162017201820192020 5-year trend
Capital Expenditures (217.4M)(175.5M)(241.7M)(278.4M)(407.3M)
Capital Expenditures (Fixed Assets) (176.1M)(168.1M)(238.7M)(254.4M)(407M)
Capital Expenditures (Other Assets) (41.3M)(7.4M)(3M)(24M)(300,000)
Net Assets from Acquisitions -(192.9M)-(135.2M)(10M)
Sale of Fixed Assets & Businesses 2.4M----
Purchase/Sale of Investments 4.5M(235.7M)323.2M(158.2M)(74.7M)
Purchase of Investments (1.08B)(1.35B)(478.5M)(568.1M)(851.7M)
Sale/Maturity of Investments 1.09B1.11B801.7M409.9M777M
Other Uses (1.2M)(43.9M)(10M)(24M)(39.1M)
Other Sources -800,0005.2M--
Net Investing Cash Flow (211.7M)(647.2M)76.7M(595.8M)(531.1M)

Financing Activities

20162017201820192020 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock (559M)(649.5M)(648.5M)(102.8M)(484.9M)
Repurchase of Common & Preferred Stk. (662.3M)(763.3M)(795.5M)(263.3M)(625.4M)
Sale of Common & Preferred Stock 103.3M113.8M147M160.5M140.5M
Proceeds from Stock Options -----
Other Proceeds from Sale of Stock 103.3M113.8M147M160.5M140.5M
Issuance/Reduction of Debt, Net 222.1M176.3M(437.3M)(10M)(800,000)
Change in Current Debt -----
Change in Long-Term Debt 222.1M176.3M(437.3M)(10M)(800,000)
Issuance of Long-Term Debt 253.5M994.7M688M18.9M16.2M
Reduction in Long-Term Debt (31.4M)(818.4M)(1.13B)(28.9M)(17M)
Other Funds 68.4M-(15.4M)(2.8M)(1.2M)
Other Uses --(15.4M)(2.8M)(1.2M)
Other Sources 68.4M----
Net Financing Cash Flow (268.5M)(473.2M)(1.1B)(115.6M)(486.9M)
Exchange Rate Effect (12.5M)7.9M(6.5M)(3M)(20.5M)
Miscellaneous Funds -----
Net Change in Cash 211.7M(111.8M)(104.2M)465M15.8M
Free Cash Flow 528.3M832.6M688.1M925M647.3M
Link to MarketWatch's Slice.